This course is developed by Medscape Education Global. Medscape is
one of the leading digital platforms for medical education. A
comprehensive array of innovative formats, in multiple languages,
insures the right educational solution is available to best achieve
desired objectives—from text-based articles to state-of-the-art
multimedia formats and the most sophisticated simulation environments.
Activity formats include Clinical Insights, Expert Perspective,
Instructional Series Programming, Next-Generation Symposia,
Patient-Case Approaches, including Simulation and Clinical
Recent developments in insulin therapy focusing on new formulations
or routes of administration and the evolving usage of continuous
glucose monitoring (CGM) have opened new frontiers in the management
of both type 1 and type 2 diabetes mellitus (T1DM and T2DM).
While novel faster- or longer-acting insulins are expanding the
options in diabetes management, the ever-growing integration of CGM in
clinical practice is also contributing to the transformation of
diabetes care over the last decade. In this program key opinion
leaders in diabetes from across the globe will take the audience on a
journey to these new frontiers in diabetes care.
Made for: Diabetologists/Endocrinologists, Primary Care Physicians
Disease areas: Diabetes
Developed by: Medscape Education Global